Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Erick Álvarez-Galván"'
Autor:
Rosa Nelly González-Ríos, Ana María Salinas-Martínez, Brenda L. Escobedo-Guajardo, María José Currás-Tuala, Everardo González-González, Ofelia Vázquez-Monsiváis, Mario Bermúdez de León, Miguel E. Aguado-Barrera, Benjamín Tovar-Cisneros, Viviana L. Mata-Tijerina, Juan Manuel Alcocer-González, Erick Álvarez-Galván, Rafael B. R. León-Cachón, Guillermo Elizondo, Lorena Puente-Lugo, Abdiel Alvarado-Díaz, Roberto Leyva-Parra, Beatriz Silva-Ramírez, Fabiola Castorena-Torres
Publikováno v:
The Pharmacogenomics Journal
Oseltamivir, a pro-drug, is the best option for treatment and chemoprophylaxis for influenza outbreaks. However, many patients treated with oseltamivir developed adverse reactions, including hypersensitivity, gastritis, and neurological symptoms. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0cdaef277f3f7dff6a46e40374a13de
http://europepmc.org/articles/PMC7223759
http://europepmc.org/articles/PMC7223759
